How many insider trades does FilingIQ track for IVVD?

FilingIQ tracks 58 Form 4 insider transactions for IVVD (Invivyd, Inc.), covering filings from Jan 19, 2024 onwards. 20 of those were filed in the last 90 days.

Are IVVD insiders net buyers or net sellers?

Across the full Form 4 history for IVVD, 1 transactions (2%) were open-market purchases and 37 (64%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does IVVD insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is IVVD in?

Invivyd, Inc. (IVVD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $428.62M.

IVVD insider trading

Healthcare

Invivyd, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

2% / 64%

Market cap

$428.62M

About Invivyd, Inc.

Invivyd, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's pipeline includes PEMGARDA (pemivibart) injection, a half-life extended investigational monoclonal antibody (mAb) for the prevention of COVID-19 in adults and adolescents; VYD2311, an mAb candidate, which is in preclinical studies for the prevention or treatment of COVID-19; and Adintrevimab that is in phase 2/3 clinical trials for the prevention and treatment of COVID-19. It also has discovery stage candidates for the prevention of seasonal influenza and COVID-19. The company has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in Waltham, Massachusetts.

Company website: invivyd.com

IVVD insider activity at a glance

FilingIQ has scored 58 insider transactions for IVVD since Jan 19, 2024. The most recent filing in our index is dated Feb 18, 2026.

Across the full history, 1 open-market purchases and 37 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on IVVD insider trades is 59.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live IVVD trades on FilingIQ Raw filings on SEC EDGAR

Latest IVVD Form 4 filings

Duke William E. Chief Financial Officer

S Aug 19, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for IVVD?: FilingIQ tracks 58 Form 4 insider transactions for IVVD (Invivyd, Inc.), covering filings from Jan 19, 2024 onwards. 20 of those were filed in the last 90 days.
Are IVVD insiders net buyers or net sellers?: Across the full Form 4 history for IVVD, 1 transactions (2%) were open-market purchases and 37 (64%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does IVVD insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is IVVD in?: Invivyd, Inc. (IVVD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $428.62M.

Methodology & sources

Every IVVD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.